Linezolid has unique immunomodulatory effects in post-influenza community acquired MRSA pneumonia.
INTRODUCTION:Post influenza pneumonia is a leading cause of mortality and morbidity, with mortality rates approaching 60% when bacterial infections are secondary to multi-drug resistant (MDR) pathogens. Staphylococcus aureus, in particular community acquired MRSA (cMRSA), has emerged as a leading ca...
Main Authors: | Urvashi Bhan, Amy B Podsiad, Melissa A Kovach, Megan N Ballinger, Venkateshwar Keshamouni, Theodore J Standiford |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4312022?pdf=render |
Similar Items
-
Cooperative interactions between TLR4 and TLR9 regulate interleukin 23 and 17 production in a murine model of gram negative bacterial pneumonia.
by: Urvashi Bhan, et al.
Published: (2010-03-01) -
The Inhibition Effect of Linezolid With Reyanning Mixture on MRSA and its Biofilm is More Significant than That of Linezolid Alone
by: Lulu Zhang, et al.
Published: (2022-01-01) -
Detection of linezolid resistance cfr gene among MRSA isolates
by: Muneeba Wali, et al.
Published: (2022-10-01) -
Linezolid and Its Immunomodulatory Effect: In Vitro and In Vivo Evidence
by: Jin Wang, et al.
Published: (2019-11-01) -
PPAR-γ Activation Inhibits Angiogenesis by Blocking ELR+CXC Chemokine Production in Non-small Cell Lung Cancer
by: Venkateshwar G. Keshamouni, et al.
Published: (2005-03-01)